Health & Pharm General

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Cashflow

🕔1/15/2020 8:40:10 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st December 2019. The Company's cash plus term deposits at the end of the quarter stood at $4.30m

Read Full Article

Regeneus Ltd (ASX:RGS) AGC Agreement Termination Paves Way for Commercial Partner

🕔12/20/2019 10:33:02 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has come to a mutual agreement with Japan-based manufacturer AGC Inc to terminate their exclusive manufacturing licence and joint venture agreement.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Finalises Draft Protocol for IBS Clinical Trial

🕔12/20/2019 8:21:26 AM

Anatara Lifesciences (ASX:ANR) is pleased to provide an update on the protocol for its clinical trial in irritable bowel syndrome (IBS) for its GaRP dietary supplement.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Achieves Preclinical Milestone

🕔12/19/2019 1:06:55 PM

Anatara Lifesciences (ASX:ANR) is pleased to provide an update on its GaRP dietary supplement preclinical milestones, which is being developed to specifically target two human gastrointestinal disorders, inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).

Read Full Article

Cann Global Limited (ASX:CGB) Strategic Landmark Cannabis Opportunity in South Africa

🕔12/19/2019 9:28:29 AM

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that it has entered into a Heads of Agreement with the South African company Koegas Medicinal Herbs (Pty) Ltd to establish a Joint Venture (CGB to hold 70%) in medicinal Cannabis production and distribution in Africa.

Read Full Article

Regeneus Ltd (ASX:RGS) Receives Innovation Grant

🕔12/18/2019 10:48:37 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has received $50K in funding as part of the Innovation Connections Grant from the Australian Government's Department of Industry, Innovation and Science.

Read Full Article

PSR Life Sciences Conference 28 November 2019: Anatara Life Sciences (ASX:ANR), Steve Lydeamore (CEO)

🕔12/13/2019 12:21:53 PM

Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore presented to investors at the Pitt Street Research Life Sciences Conference in Sydney last month. During his presentation, Steve spoke to the Anatara story and the exciting year we have ahead with upcoming corporate milestones on both our human and animal health product opportunities.

Read Full Article